Viewing Study NCT01179594


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-28 @ 6:46 PM
Study NCT ID: NCT01179594
Status: WITHDRAWN
Last Update Posted: 2017-02-17
First Post: 2010-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module